MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number D-EVOLUTFX-2329 |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
|
Patient Problems
Non specific EKG/ECG Changes (1817); Low Blood Pressure/ Hypotension (1914); Cardiac Perforation (2513); Pericardial Effusion (3271); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/11/2024 |
Event Type
Injury
|
Event Description
|
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, a right ventricular perforation oc curred.The valve was placed and the patient left the operating room. after pacemaker removal in the intensive care unit (icu), the patient's blood pressure decreased.Pericardial effusion was observed, so drainage was performed.Hemostasis was achieved during the night, and the patient was kept under observation.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Section d references the main component of the system.Other medical products in use during the event include: brand name evolut fx valve; product id evolutfx-29 (serial: (b)(6)); product type: 0195-heart valves; implant date (b)(6) 2024.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information was received that the perforation occurred at the end of the procedure.Per the physician, the temporary pacemaker in the right ventricle caused the perforation that led to the subsequent pericardial effusion.Additionally, the guidewire, delivery catheter system (dcs), and valve did not cause or contribute to the perforation or the pericardial effusion.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Additional information received shows that there is no information to reasonably suggest that the dcs and valve in this report may have caused or contributed to a death or serious injury or that the device in this report has malfunctioned.Therefore, this event does not meet the reporting requirements in 21 cfr 803.Updated data: b5.D4.H4.H6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|